This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Nov;15(6):e70-e71.

doi: 10.1016/j.jcf.2016.09.010. Epub 2016 Oct 14.

Coronary artery disease in cystic fibrosis: An emerging concern?

Kate Skolnik¹, Robert D Levy², Pearce G Wilcox³, Bradley S Quon³

Affiliations

Affiliations

¹ Department of Medicine, University of Calgary, AB, Canada. Electronic address: kate.skolnik@albertahealthservices.ca.
² Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
³ Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

PMID: 27751792
DOI: 10.1016/j.jcf.2016.09.010

Free article

Coronary artery disease in cystic fibrosis: An emerging concern?

Kate Skolnik et al. J Cyst Fibros. 2016 Nov.

Free article

. 2016 Nov;15(6):e70-e71.

doi: 10.1016/j.jcf.2016.09.010. Epub 2016 Oct 14.

Authors

Kate Skolnik¹, Robert D Levy², Pearce G Wilcox³, Bradley S Quon³

Affiliations

¹ Department of Medicine, University of Calgary, AB, Canada. Electronic address: kate.skolnik@albertahealthservices.ca.
² Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
³ Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

PMID: 27751792
DOI: 10.1016/j.jcf.2016.09.010

No abstract available

Keywords: Atherosclerosis; Coronary artery disease; Diabetes; Dyslipidemia; Heart disease.

PubMed Disclaimer

Similar articles

Spontaneous coronary artery dissection associated with coughing.
Sivam S, Yozghatlian V, Dentice R, McGrady M, Moriarty C, Di Michiel J, Bye PT, Rees D. Sivam S, et al. J Cyst Fibros. 2014 Mar;13(2):235-7. doi: 10.1016/j.jcf.2013.10.003. Epub 2013 Oct 21. J Cyst Fibros. 2014. PMID: 24157355 No abstract available.
Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A. Shroff R, et al. J Clin Endocrinol Metab. 2007 Dec;92(12):4609-14. doi: 10.1210/jc.2007-1343. Epub 2007 Sep 11. J Clin Endocrinol Metab. 2007. PMID: 17848406
Atherosclerosis and plaque rupture: an update.
Afzal MN, Saeed SA, Shah BH. Afzal MN, et al. J Pak Med Assoc. 1999 Feb;49(2):37-43. J Pak Med Assoc. 1999. PMID: 10513436 Review. No abstract available.
An infant with transposition and cystic fibrosis.
Cook AL, Crawford KL, Williams DA. Cook AL, et al. Cardiol Young. 2009 Feb;19(1):111-2. doi: 10.1017/S1047951108003363. Epub 2008 Dec 2. Cardiol Young. 2009. PMID: 19046479
[Myocardial and coronary vessel dysfunction in diabetes I patients].
Konduracka E, Galicka-Latała D, Piwowarska W, Sieradzki J. Konduracka E, et al. Przegl Lek. 2002;59(7):514-8. Przegl Lek. 2002. PMID: 12516240 Review. Polish.

See all similar articles

Cited by

What the future holds: cystic fibrosis and aging.
Blankenship S, Landis AR, Harrison Williams E, Peabody Lever JE, Garcia B, Solomon G, Krick S. Blankenship S, et al. Front Med (Lausanne). 2024 Jan 8;10:1340388. doi: 10.3389/fmed.2023.1340388. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38264036 Free PMC article. Review.
Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis.
Despotes KA, Ceppe AS, Donaldson SH. Despotes KA, et al. J Cyst Fibros. 2023 Nov;22(6):1024-1026. doi: 10.1016/j.jcf.2023.10.002. Epub 2023 Oct 12. J Cyst Fibros. 2023. PMID: 37838486 Free PMC article.
Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study.
Frost F, Nazareth D, Fauchier L, Wat D, Shelley J, Austin P, Walshaw MJ, Lip GYH. Frost F, et al. Eur Respir J. 2023 Oct 26;62(4):2300174. doi: 10.1183/13993003.00174-2023. Print 2023 Oct. Eur Respir J. 2023. PMID: 37474158 Free PMC article.
Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?
Trandafir LM, Frăsinariu OE, Țarcă E, Butnariu LI, Leon Constantin MM, Moscalu M, Temneanu OR, Melinte Popescu AS, Popescu MGM, Stârcea IM, Cojocaru E, Moisa SM. Trandafir LM, et al. Nutrients. 2023 Jan 8;15(2):314. doi: 10.3390/nu15020314. Nutrients. 2023. PMID: 36678185 Free PMC article. Review.
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents.
Ode KL, Ballman M, Battezzati A, Brennan A, Chan CL, Hameed S, Ismail HM, Kelly A, Moran AM, Rabasa-Lhoret R, Saxby NA, Craig ME. Ode KL, et al. Pediatr Diabetes. 2022 Dec;23(8):1212-1228. doi: 10.1111/pedi.13453. Pediatr Diabetes. 2022. PMID: 36537525 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance
- MedlinePlus Health Information